Form 4: Colgate-Palmolive Director Nelson Receives Stock Grant and Option Award
SEC Form 4 Filing
Director Kimberly A. Nelson received a stock grant and option award from Colgate-Palmolive on May 12, 2025, according to a Form 4 filing with the SEC.
Summary
- On May 12, 2025, Kimberly A. Nelson, a director of Colgate-Palmolive, received 2,019 shares of common stock as an annual director stock grant.
- These shares were credited to a stock unit account under the company's incentive compensation plan.
- Nelson also received an option to buy 2,272 shares of Colgate-Palmolive common stock at an exercise price of $89.14.
- The stock options vest in equal annual installments over three years, starting May 12, 2026, and expire on May 12, 2033.
- Following these transactions, Nelson directly owns 2,272 derivative securities and 9,360 shares of common stock.
- Nelson also indirectly owns 575 shares through a family trust, 215 shares through a spouse, and 1,799 shares through another trust.
Sentiment
Score: 7
Explanation: The document reflects a routine executive compensation event, which is generally viewed neutrally to positively as it aligns management interests with shareholders.
Positives
- The stock grant and option award align the director's interests with those of the shareholders.
- The vesting schedule of the stock options encourages long-term commitment from the director.
Future Outlook
The director's holdings will increase over time as the stock options vest and are exercised, aligning their interests with the company's long-term performance.
Industry Context
Stock grants and options are common forms of executive compensation in publicly traded companies like Colgate-Palmolive, used to incentivize performance and retain key personnel.
Comparison to Industry Standards
- Executive compensation packages, including stock options and grants, are standard practice among large, publicly traded consumer goods companies such as Procter & Gamble (P&G) and Unilever.
- The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance and retention.
- The number of shares and options granted are typically determined based on the executive's role, responsibilities, and the company's overall compensation strategy.
Stakeholder Impact
- Shareholders may view the stock grant and option award positively as it aligns the director's interests with the company's performance.
- Employees may see this as a standard practice for executive compensation.
Key Dates
| Date | Description |
|---|---|
| 05/12/2025 | Date of stock grant and option award |
| 05/12/2026 | First vesting date for stock options |
| 05/12/2033 | Expiration date for stock options |
| 05/14/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Director, Stock Grant, Stock Option, Colgate-Palmolive, Nelson, Incentive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.